Alaunos Therapeutics, Inc.

Filed a patent for "identification of neoantigen-reactive t cell receptors" on Tue, March 21, 2023

Filed a patent for "methods for identifying neoantigen-reactive t cell receptors" on Sun, November 6, 2022

Filed a patent for "recombinant vectors comprising polycistronic expression cassettes and methods of use thereof" on Thu, June 29, 2023

Filed a patent for "recombinant vectors comprising polycistronic expression cassettes and methods of use thereof" on Thu, May 30, 2024

Filed a patent for "methods for identifying neoantigen-reactive t cell receptors" on Mon, March 21, 2022

Filed a patent for "methods of treating glioblastoma" on Thu, December 14, 2023